GL1X · GenesisL1 explorer

Research workbench

An anti-urokinase plasminogen activator receptor (upar) antibody: crystal structure and binding epitope

Analyse An anti-urokinase plasminogen activator receptor (upar) antibody: crystal… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2FAT
Type
protein
Length
426 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Fab atn-615, light chain; Fab atn-615, heavy chain
Pockets
5 · best druggability 0.54

Structure

x-ray diffraction · 2 distinct chains · 6% helix, 52% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
LFab atn-615, light chainprotein2126% helix, 51% strand—
HFab atn-615, heavy chainprotein2146% helix, 53% strand—

Pockets

5 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13400.540.7440empty
2560.450.8420empty
3720.300.7419empty
4680.280.7315empty
5680.280.7217empty

Interfaces

1 interface between chains.

  • L–H · 1795 Ų buried · 16 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 disulfide (disulfide).

Compared structures

  • 2FAT · An anti-urokinase plasminogen activator receptor (UPAR) antibody: Crystal structure and… · the same entry in another collection · chain L against L, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.